SCHEMBL6169819

SCHEMBL6169819

CCCC(=O)N(Cc1ccc(F)cc1)c1cc(C(=O)OCC)ccc1[N+](=O)[O-]

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.46
ALDH1A1 P00352 4/20 0.46
RAB9A P51151 2/20 0.46
NPC1 O15118 1/20 0.46
PKM P14618 1/20 0.46
CRHBP P24387 1/20 0.46
CRHR2 Q13324 1/20 0.46
KMT2A Q03164 4/20 0.44
LMNA P02545 2/20 0.43
KDM4E B2RXH2 1/20 0.43
POLB P06746 1/20 0.43
GSTP1 P09211 1/20 0.43
GSTM2 P28161 1/20 0.43
CETP P11597 4/20 0.42
MEN1 O00255 3/20 0.42
PTGER4 P35408 1/20 0.41
LTB4R2 Q9NPC1 1/20 0.41
MAPK1 P28482 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172670 0.90 KMT2A (0.53) MAPTALDH1A1RAB9ANPC1PKM
SCHEMBL6169034 0.90 MAPT (0.48) MAPTALDH1A1RAB9ANPC1PKM
SCHEMBL6169818 0.89 MAPT (0.44) MAPTALDH1A1RAB9ANPC1PKM
SCHEMBL6172420 0.85 MAPT (0.45) MAPTALDH1A1RAB9ANPC1PKM
SCHEMBL6169119 0.83 KMT2A (0.46) MAPTALDH1A1RAB9ANPC1PKM
SCHEMBL6168617 0.82 ALDH1A1 (0.50) MAPTALDH1A1RAB9ANPC1PKM
SCHEMBL6170283 0.81 MAPT (0.45) MAPTALDH1A1RAB9ANPC1PKM
SCHEMBL6170740 0.81 KMT2A (0.46) MAPTALDH1A1RAB9ANPC1PKM
SCHEMBL6172637 0.80 MAPT (0.47) MAPTALDH1A1RAB9ANPC1PKM
SCHEMBL6172403 0.80 MAPT (0.46) MAPTALDH1A1RAB9ANPC1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882718-B1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-08-31 EP disclosed
US-6352985-B1 CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 US disclosed
US-6166219-A Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-0882718-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed